RA PHARMACEUTICALS, INC. Debt Conversion, Converted Instrument, Amount
RA PHARMACEUTICALS, INC. reported Debt Conversion, Converted Instrument, Amount of $5.11 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2016-11-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2016-11-29
- 2015-09-30: Debt Conversion, Converted Instrument, Amount 9 month $5.11M.
| Period end | Debt Conversion, Converted Instrument, Amount 9 month |
|---|---|
| 2015-09-30 | $5.11M 10-Q · filed 2016-11-29 |